Literature DB >> 27836950

Adrenal vein sampling in primary aldosteronism: concordance of simultaneous vs sequential sampling.

Mohamed-Karji Almarzooqi1, Miguel Chagnon2, Gilles Soulez1,3, Marie-France Giroux1, Patrick Gilbert1, Vincent L Oliva1, Pierre Perreault1, Louis Bouchard1, Isabelle Bourdeau4, André Lacroix4, Eric Therasse5.   

Abstract

OBJECTIVE: Many investigators believe that basal adrenal venous sampling (AVS) should be done simultaneously, whereas others opt for sequential AVS for simplicity and reduced cost. This study aimed to evaluate the concordance of sequential and simultaneous AVS methods. DESIGN AND METHODS: Between 1989 and 2015, bilateral simultaneous sets of basal AVS were obtained twice within 5 min, in 188 consecutive patients (59 women and 129 men; mean age: 53.4 years). Selectivity was defined by adrenal-to-peripheral cortisol ratio ≥2, and lateralization was defined as an adrenal aldosterone-to-cortisol ratio ≥2, the contralateral side. Sequential AVS was simulated using right sampling at -5 min (t = -5) and left sampling at 0 min (t = 0).
RESULTS: There was no significant difference in mean selectivity ratio (P = 0.12 and P = 0.42 for the right and left sides respectively) and in mean lateralization ratio (P = 0.93) between t = -5 and t = 0. Kappa for selectivity between 2 simultaneous AVS was 0.71 (95% CI: 0.60-0.82), whereas it was 0.84 (95% CI: 0.76-0.92) and 0.85 (95% CI: 0.77-0.93) between sequential and simultaneous AVS at respectively -5 min and at 0 min. Kappa for lateralization between 2 simultaneous AVS was 0.84 (95% CI: 0.75-0.93), whereas it was 0.86 (95% CI: 0.78-0.94) and 0.80 (95% CI: 0.71-0.90) between sequential AVS and simultaneous AVS at respectively -5 min at 0 min.
CONCLUSIONS: Concordance between simultaneous and sequential AVS was not different than that between 2 repeated simultaneous AVS in the same patient. Therefore, a better diagnostic performance is not a good argument to select the AVS method.
© 2017 European Society of Endocrinology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27836950     DOI: 10.1530/EJE-16-0701

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  5 in total

Review 1.  Primary aldosteronism - a multidimensional syndrome.

Authors:  Adina F Turcu; Jun Yang; Anand Vaidya
Journal:  Nat Rev Endocrinol       Date:  2022-08-31       Impact factor: 47.564

2.  Variability of Aldosterone Measurements During Adrenal Venous Sampling for Primary Aldosteronism.

Authors:  Nicholas Yozamp; Gregory L Hundemer; Marwan Moussa; Johnathan Underhill; Tali Fudim; Barry Sacks; Anand Vaidya
Journal:  Am J Hypertens       Date:  2021-02-18       Impact factor: 3.080

Review 3.  Subtype Diagnosis of Primary Aldosteronism: Is Adrenal Vein Sampling Always Necessary?

Authors:  Fabrizio Buffolo; Silvia Monticone; Tracy A Williams; Denis Rossato; Jacopo Burrello; Martina Tetti; Franco Veglio; Paolo Mulatero
Journal:  Int J Mol Sci       Date:  2017-04-17       Impact factor: 5.923

4.  The influence of the peripheral cortisol fluctuation on the success rate of adrenal venous sampling.

Authors:  Chin-Chen Chang; Bo-Ching Lee; Kao-Lang Liu; Yeun-Chung Chang; Vin-Cent Wu; Kuo-How Huang; Tung-Hsin Wu
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

Review 5.  The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism.

Authors:  Gian Paolo Rossi; Valeria Bisogni; Alessandra Violet Bacca; Anna Belfiore; Maurizio Cesari; Antonio Concistrè; Rita Del Pinto; Bruno Fabris; Francesco Fallo; Cristiano Fava; Claudio Ferri; Gilberta Giacchetti; Guido Grassi; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Giuseppe Maiolino; Dario Manfellotto; Pietro Minuz; Silvia Monticone; Alberto Morganti; Maria Lorenza Muiesan; Paolo Mulatero; Aurelio Negro; Gianfranco Parati; Martino F Pengo; Luigi Petramala; Francesca Pizzolo; Damiano Rizzoni; Giacomo Rossitto; Franco Veglio; Teresa Maria Seccia
Journal:  Int J Cardiol Hypertens       Date:  2020-04-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.